Midday Movers: JDA Software, Tommy Hilfiger, Healtheon/WebMD and Saba Software - TheStreet

Midday Movers: JDA Software, Tommy Hilfiger, Healtheon/WebMD and Saba Software

Publish date:

A first-rate earnings preview boosted JDA Software's (JDAS) shares 3 3/8, or 23.1%, to 18. The company reported this morning that it expects first-quarter earnings to beat analysts' expectations. The three-analyst consensus calls for JDA Software to come in at 3 cents a share. Based on preliminary figures, JDA said it anticipates software license revenue to be approximately $15 million, more than double the year-ago $7.4 million.

Mergers, acquisitions and joint ventures

Warnaco Group


has made a second bid for privately held fashion house

Calvin Klein


The Wall Street Journal

reported. Warnaco made another bid for the company in the wake of the failure of merger talks between Calvin Klein and

Tommy Hilfiger


, the newspaper reported, citing people familiar with the situation. The new bid is said to be under the $1 billion asking price and is subject to due diligence, the newspaper reported. Warnaco Group remained unchanged at 10 7/8.

Separately, Tommy Hilfiger said it anticipates overall revenue for fiscal 2001 will be unchanged to 5% lower as compared with fiscal 2000. It warned that it expects net income for the year ending March 31, 2001, to be 30% to 40% lower than fiscal 2000, excluding special charges to be taken in the fourth quarter of fiscal 2000. The company expects fourth-quarter earnings, before special charges, to come in toward the lower end of the previously stated range of 35 cents to 45 cents. The 15-analyst estimate calls for the company to earn 39 cents a share in the fourth-quarter fiscal 2000 period.

Tommy Hilfiger also said its board had approved a stock-buyback program of up to $150 million.

Merrill Lynch downgraded the Tommy Hilfiger shares to neutral from accumulate. Salomon Smith Barney also cut the shares to neutral from outperform. Tommy Hilfiger got hit this afternoon: the company's shares fell 4 5/16, or 31.2%, to 9 1/2.



upped its stock offer for ice cream competitor

Ben & Jerry's Homemade


to roughly $35-$38 a share, reported

The Wall Street Journal

. Dreyer's lost 1 1/8 to 25, while Ben & Jerry's Homemade gained 1 11/16, or 5.2%, to 34 1/4.


(VFC) - Get Report

said it will buy

North Face


for $2 a share. VF shares were unchanged at 25 1/16 and North Face was up 21/32, or 53.9%, to 1 27/32.

Earnings/revenue reports and previews


Earnings estimates from First Call/Thomson Financial; earnings reported on a diluted basis unless otherwise specified.




stock price jumped 6 15/16, or 31.7%, to 28 5/8 after it announced that it anticipates first-quarter revenues to exceed $62 million and it expects to post a loss before non-cash charges of less than $90 million. The company said it expects to announce its first-quarter results late this month or in early May.

Separately, two directors of Healtheon/WebMD, Jim Clark and John Doerr, have asked the company to grant an exception to its trading window restrictions so they can buy up stock -- Clark wants to buy up to $200 million, while Doerr intends to invest up to $20 million.


(ATVI) - Get Report

, a video-game maker, fell 1 15/16, or 17.5%, to 9 1/8 after it reported that is taking a pretax charge of $66 million as part of a restructuring. The company expects the actions will result in pretax savings of $11 million in fiscal year 2001.


(CERN) - Get Report

hopped 5 3/8, or 21.5%, to 30 3/8 following news that it expects to post first-quarter earnings of roughly 7 cents a share, which would beat the 18-analyst estimate of 3 cents.



, a bank holding company for MBNA America Bank, foresees first-quarter earnings of 28 cents a share, in line with the 23-analyst estimate and up from the year-ago 22 cents. MBNA climbed 4 5/8, or 21%, to 26 5/8.


(SBUX) - Get Report

said Howard Schultz will

step down as CEO to take a more visionary role at the company, focusing on long-term strategy. Schultz, whose resignation will be effective June 1, will stay on as chairman of the Seattle-based company and will assume the newly created title of chief global strategist. He will be succeeded by COO and President Orin Smith.

The company also reported that March

same-store sales rose 10%. Shares of Starbucks were up 1 1/16 to 38 5/8.

Offerings and stock actions

Credit Suisse First Boston

priced a 5.5 million-share for

Numerical Technologies


above its expected $11-$13 price range, at $14 a share. Numerical Technologies hopped 12 3/8, or 88.4%, to 26 3/8.


Goldman Sachs

priced a 4-million share offering for

SABA Software


above its expected $12-$14 price range at $15 a share, SABA 's stock soared 20 1/2, or 136.6%, to 35 1/2.

ASM International


, the Dutch semiconductor equipment maker, set the price for its offer of 5 million shares at $29 a share. The company is offering 3.5 million shares and

Applied Materials

(AMAT) - Get Report

, as selling shareholder, is offering 1.5 million. The stock price rose 4, or 13.8%, to 33.


(FNSR) - Get Report

upped the size of its secondary offering to 7.7 million shares from 7 million. The offering is priced at $100 a share. Finisar rose 1 5/16 to 101 3/4.

Bear Stearns

priced a 10 million-share IPO for



at the top end of its $14-$16 price range at $16. GoAmerica lifted 3/16 to 16 3/16.

KPN Telecom


boosted 11 1/4, or 10.7%, to 116 1/4 after the company reported that its shareholders would vote to set a 2-for-1 stock split on April 27.

J.P. Morgan


Credit Suisse First Boston

priced a 10 million-share IPO for

Lexicon Genetics


at the low end of its $22 to $24 price range, $22. Lexicon Genetics slumped 3 3/4, or 17.1%, to 18 1/4.

Chase H&Q

priced a 4 million-share IPO for


(LPSN) - Get Report

below its expected price of $10, at $8 a share. LivePerson gained 1 13/16, or 22.7%, to 9 13/16.

Robertson Stephens

priced a 7.7 million-share IPO for



in the middle of its expected price range of $9 to $11, at $10 a share. Opus360 advanced 3, or 30%, to 13.

CIBC World Markets

priced a 7.5 million share offering for



midrange at $28.50 a share.

Analyst actions

This morning,

Donaldson Lufkin & Jenrette

upgraded its rating on athletic shoe and clothing giant


(NKE) - Get Report

to buy from market perform. Nike gained 1 3/16 to 42 3/4.

Allied Waste


slipping 13/16, or 10.8%, to 6 11/16: DOWN to neutral from buy at





gained 1 3/8 to 46 3/8: STARTED with a market outperform rating at

Goldman Sachs




falling 1/2 to 49: UP to buy from neutral at Bears Stearns.



climbed 5 13/16, or 10.4%, to 72 7/16: price target UP to 100 from 70 at

Prudential Securities



(DD) - Get Report

rose 11/16 to 57: UP to buy from neutral at PaineWebber; price target of 70.

This morning,

Merrill Lynch

analyst David Anders initiated or reinstated coverage of the gaming industry on several stocks including:

Argosy Gaming


at accumulate with a 19 price target,



INITIATED at accumulate,



at accumulate,



at accumulate and a 26 price target,

International Game Technology

(IGT) - Get Report

at accumulate,



at accumulate with a 23 price target,

MGM Grand


at buy with a 32 price target and

Station Casinos

(STN) - Get Report

at accumulate and a 28 price target. Argosy added 3/16 to 14 3/4, Aztar rose 7/16 to 10, Gtech gained 7/16 to 19 9/16, Harrah's rose 3/8 to 19 7/16, International Game Technology rose 1/8 to 23, Mandalay moved up 3/4 to 18, MGM moved up 1 3/8, or 5.4%, to 26 3/4 and Station Casinos rose 3/8 to 24 1/8.

Global Crossing


gained 1 to 38 7/16: coverage STARTED as an outperform at

Lehman Brothers




added 1/16 to 17 13/16: UP to buy from attractive at PaineWebber.



inched 1/4 to 44: coverage STARTED with an outperform at

Morgan Stanley Dean Witter




lifting 1 15/16, or 5.9%, to 34 3/4: price target UP to 49 from 45 at DLJ.

Matrix One


moving up 8 1/8, or 30.7%, to 35 1/8: rating UP to "recommended for purchase" list from outperform at Goldman Sachs.



gained 5 1/8, or 7.1%, to 77 3/16: NEW buy at

Credit Suisse First Boston

; price target of 116.

Midway Games


dropped 6 5/16, or 44.2%, to 7 15/16: rating DOWN to hold from buy at

ING Barings


Ribozyme Pharmaceuticals


added 2, or 10.1%, to 21 7/8: STARTED as a buy at

Chase H&Q


Safeguard Scientifics

(SFE) - Get Report

rose 8 3/8, or 16.7%, to 58 15/16: UP to strong buy at

Prudential Securities

; STARTED as a buy with a 100 price target at Lehman Brothers.



sailed up 12 7/16, or 7.4%, to 181 1/16: NEW buy rating at

Thomas Weisel

by analyst Max Schuetz.



tacked on 1 7/16 to 30 15/16: rating UP to buy from hold and price target set at 40 at

ABN Amro




gained 1 1/4 to 42 1/2: STARTED with a strong buy rating and a 90 price target at ING Barings.


Prosecutors in the federal antitrust probe of auction house giants


(BID) - Get Report



have evidence that a plan to restrict competition by fixing commissions charged to buyers was set in motion by the chairmen of the two firms at the time,

The New York Times

reported, citing people involved in the probe.

The two chairmen, Sotheby's A. Alfred Taubman and Christie's Sir Anthony Tennant, talked about the arrangement in person and then instructed their chief executives to carry out the plan, according to the


story. Sotheby's was lately down 1/4 to 16 15/16.

The Inside Wall Street column this week in

Business Week

written by Gene Marcial says that

Hughes Electronics


, the satellite company, 69% of whose stock is owned by

General Motors

(GM) - Get Report

, is a buyout target. Hughes was lately rising 2 1/2 to 123 1/2.

The column also offers up bullish pieces on

Carolina Power & Light

(CPL) - Get Report



(CVS) - Get Report

, the pharmacy chain. Carolina Power slipped 1/16 to 32 3/8 while CVS was off 1/4 to 38 9/16.



, the discount retailing chain, inched up 1/8 to 9 1/4 after saying it is voluntarily recalling about 280,000 "Little Ones" children's decorative lamps, which it said can short-circuit and pose a fire hazard.

The Heard on the Street column in the

Wall Street Journal

discusses how investors can get stung by rookie analysts' inflated recommendations, such as

SG Cowen

Thomas Bock's strong buy recommendation and price target for